RxDoctor Payments DataLook up a doctor →

Thomas Berry, MD

Interventional Pain Medicine · Lacombe, LANPI 1629243431

Payments from drug & device makers

$20,960in general payments, 2019–2025

Across 353 payments — averaging $59.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Relievant Medsystems, Inc.$4K
  • Novartis$4K
  • Saluda Medical Americas, Inc.$3K
  • Abbott$2K
  • Spinal Simplicity, LLC$2K
  • Boston Scientific$2K
  • plus $5K from 45 others
$260in research payments, 2019–2025

Across 3 payments — averaging $86.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Saluda Medical Americas, Inc.$260

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$20,960 in reported general payments places this provider in the 85th percentile of 57 interventional pain medicine providers in Louisiana.

See all interventional pain medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$170,721
Medicare patients
274
Services billed
2,853

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Lacombe

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →